HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Georgios Tsoulfas Selected Research

Collagen Type VI

2/2020Prognostic value of COL6A3 in pancreatic adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Georgios Tsoulfas Research Topics

Disease

10Neoplasms (Cancer)
10/2022 - 06/2007
10Hepatocellular Carcinoma (Hepatoma)
06/2022 - 06/2007
4COVID-19
10/2023 - 01/2020
4Reperfusion Injury
09/2023 - 07/2012
4End Stage Liver Disease
11/2022 - 12/2007
4Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2011
4Neoplasm Metastasis (Metastasis)
12/2021 - 01/2012
3Infections
02/2023 - 06/2011
3Liver Diseases (Liver Disease)
10/2020 - 08/2013
3Obesity
10/2020 - 10/2017
3Wounds and Injuries (Trauma)
01/2020 - 08/2013
3Fibrosis (Cirrhosis)
07/2012 - 06/2007
2Chronic Kidney Failure (Chronic Renal Failure)
10/2023 - 01/2022
2Ischemia
09/2023 - 11/2013
2Frailty
02/2023 - 11/2022
2Pneumonia (Pneumonitis)
10/2022 - 06/2022
2Hypertension (High Blood Pressure)
01/2022 - 10/2020
2Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2013
2Liver Neoplasms (Liver Cancer)
01/2022 - 06/2017
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 02/2020
2Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2020 - 08/2019
2Alcoholic Fatty Liver
10/2020 - 08/2019
2Adenocarcinoma
02/2020 - 10/2014
1Pulmonary Arterial Hypertension
09/2023
1Inflammation (Inflammations)
09/2023
1Empyema
10/2022
1Chylothorax
10/2022
1Fistula
10/2022
1Pulmonary Embolism
10/2022
1Cardiac Arrhythmias (Arrythmia)
10/2022
1Atrial Fibrillation
06/2022
1Wound Infection (Wound Infections)
06/2022
1Esophageal Neoplasms (Esophageal Cancer)
06/2022
1Hearing Loss (Hearing Impairment)
01/2022
1Gestational Diabetes (Gestational Diabetes Mellitus)
01/2022
1Breast Neoplasms (Breast Cancer)
01/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022
1Alcoholism (Alcohol Abuse)
01/2022
1Ulcerative Colitis
01/2022
1Coronary Disease (Coronary Heart Disease)
01/2022
1Dementia (Dementias)
01/2022
1Endometriosis
01/2022
1Ischemic Stroke
01/2022
1Pulmonary Tuberculosis
01/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Melanoma (Melanoma, Malignant)
01/2022
1Ovarian Neoplasms (Ovarian Cancer)
01/2022
1Cholangiocarcinoma
10/2021
1Biliary Atresia
09/2021
1Ectopic Pregnancy
11/2020
1Stillbirth
11/2020
1Insulin Resistance
10/2020
1Carcinogenesis
01/2020
1Primary Hyperparathyroidism
09/2019
1Non-alcoholic Fatty Liver Disease
08/2019
1Surgical Wound
12/2017
1Postoperative Pain
12/2017
1Sarcopenia
10/2017

Drug/Important Bio-Agent (IBA)

5MicroRNAs (MicroRNA)IBA
01/2022 - 01/2014
2Antiviral Agents (Antivirals)IBA
02/2023 - 08/2019
2Immune Checkpoint InhibitorsIBA
06/2022 - 01/2021
2DNA (Deoxyribonucleic Acid)IBA
02/2021 - 02/2015
2Biomarkers (Surrogate Marker)IBA
02/2020 - 01/2020
1BNT162 VaccineIBA
10/2023
1Epoprostenol (Prostacyclin)FDA LinkGeneric
09/2023
1CytokinesIBA
09/2023
1Adenosine Triphosphate (ATP)IBA
09/2023
1treprostinilFDA Link
09/2023
1hydroxide ionIBA
10/2021
1Formaldehyde (Formol)FDA Link
02/2021
1ParaffinIBA
02/2021
1atezolizumabIBA
01/2021
1Calcibiotic Root Canal SealerIBA
01/2021
1pembrolizumabIBA
01/2021
1Bevacizumab (Avastin)FDA Link
01/2021
1IpilimumabIBA
01/2021
1NivolumabIBA
01/2021
1Epidermal Growth Factor (EGF)IBA
01/2021
1Triglycerides (Triacylglycerol)IBA
10/2020
1HDL CholesterolIBA
10/2020
1Collagen Type VIIBA
02/2020
1AntagomirsIBA
01/2020
1Parathyroid Hormone (Parathormone)IBA
09/2019

Therapy/Procedure

21Liver Transplantation
09/2023 - 06/2007
7Therapeutics
02/2020 - 06/2007
4Transplantation
02/2023 - 06/2007
3Organ Transplantation
10/2023 - 01/2020
3Immunotherapy
02/2023 - 01/2021
3Length of Stay
10/2022 - 12/2017
3Hepatectomy
10/2021 - 01/2011
2Kidney Transplantation
10/2023 - 02/2023
2Drug Therapy (Chemotherapy)
01/2012 - 01/2011
1Intravenous Administration
09/2023
1Pneumonectomy (Lung Volume Reduction)
10/2022
1Operative Time
06/2022
1Esophagectomy
06/2022
1Hepatic Portoenterostomy
09/2021
1Cesarean Section (Caesarean Section)
11/2020
1Induced Labor
11/2020
1Bariatric Surgery
10/2020